These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

777 related items for PubMed ID: 10326220

  • 1. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.
    Koren A, Segal-Kupershmit D, Zalman L, Levin C, Abu Hana M, Palmor H, Luder A, Attias D.
    Pediatr Hematol Oncol; 1999; 16(3):221-32. PubMed ID: 10326220
    [Abstract] [Full Text] [Related]

  • 2. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP.
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [Abstract] [Full Text] [Related]

  • 3. Hydroxyurea therapy in children severely affected with sickle cell disease.
    Scott JP, Hillery CA, Brown ER, Misiewicz V, Labotka RJ.
    J Pediatr; 1996 Jun; 128(6):820-8. PubMed ID: 8648542
    [Abstract] [Full Text] [Related]

  • 4. [Effect of hydroxyurea on hemoglobin S].
    Torres AF, Eberle SE, Sciuccati G, Bonduel M.
    Medicina (B Aires); 2003 Jun; 63(2):140-2. PubMed ID: 12793083
    [Abstract] [Full Text] [Related]

  • 5. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R, Hsieh MM, Zhao X, Calvaruso G, Rigano P, Renda D, Tisdale JF, Maggio A.
    Int J Mol Sci; 2018 Feb 28; 19(3):. PubMed ID: 29495591
    [Abstract] [Full Text] [Related]

  • 6. On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease.
    el-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F, Warsy AS.
    Acta Haematol; 1995 Feb 28; 94(3):128-34. PubMed ID: 7502628
    [Abstract] [Full Text] [Related]

  • 7. [Sickle cell anemia in children: value of hydroxyurea in severe forms].
    Oury AP, Hoyoux C, Dresse MF, Chantraine JM.
    Arch Pediatr; 1997 Sep 28; 4(9):839-44. PubMed ID: 9345564
    [Abstract] [Full Text] [Related]

  • 8. Real-Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT-HU cohort study.
    de Montalembert M, Voskaridou E, Oevermann L, Cannas G, Habibi A, Loko G, Joseph L, Colombatti R, Bartolucci P, Brousse V, Galactéros F, All ESCORT HU Investigators.
    Am J Hematol; 2021 Oct 01; 96(10):1223-1231. PubMed ID: 34224583
    [Abstract] [Full Text] [Related]

  • 9. Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease.
    Jain DL, Sarathi V, Desai S, Bhatnagar M, Lodha A.
    Hemoglobin; 2012 Oct 01; 36(4):323-32. PubMed ID: 22734586
    [Abstract] [Full Text] [Related]

  • 10. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
    Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP, Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
    N Engl J Med; 2018 Jul 19; 379(3):226-235. PubMed ID: 30021096
    [Abstract] [Full Text] [Related]

  • 11. Minimal doses of hydroxyurea for sickle cell disease.
    Lima CS, Arruda VR, Costa FF, Saad ST.
    Braz J Med Biol Res; 1997 Aug 19; 30(8):933-40. PubMed ID: 9361721
    [Abstract] [Full Text] [Related]

  • 12. Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia.
    Darbari DS, Nouraie M, Taylor JG, Brugnara C, Castro O, Ballas SK.
    Eur J Haematol; 2014 Apr 19; 92(4):341-5. PubMed ID: 24330217
    [Abstract] [Full Text] [Related]

  • 13. Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa.
    John CC, Opoka RO, Latham TS, Hume HA, Nabaggala C, Kasirye P, Ndugwa CM, Lane A, Ware RE.
    N Engl J Med; 2020 Jun 25; 382(26):2524-2533. PubMed ID: 32579813
    [Abstract] [Full Text] [Related]

  • 14. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.
    Blood Cells Mol Dis; 2000 Oct 25; 26(5):453-66. PubMed ID: 11112383
    [Abstract] [Full Text] [Related]

  • 15. Effects of hydroxyurea treatment for patients with hemoglobin SC disease.
    Luchtman-Jones L, Pressel S, Hilliard L, Brown RC, Smith MG, Thompson AA, Lee MT, Rothman J, Rogers ZR, Owen W, Imran H, Thornburg C, Kwiatkowski JL, Aygun B, Nelson S, Roberts C, Gauger C, Piccone C, Kalfa T, Alvarez O, Hassell K, Davis BR, Ware RE.
    Am J Hematol; 2016 Feb 25; 91(2):238-42. PubMed ID: 26615793
    [Abstract] [Full Text] [Related]

  • 16. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
    Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M.
    JAMA; 2003 Apr 02; 289(13):1645-51. PubMed ID: 12672732
    [Abstract] [Full Text] [Related]

  • 17. Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease.
    de Montalembert M, Belloy M, Bernaudin F, Gouraud F, Capdeville R, Mardini R, Philippe N, Jais JP, Bardakdjian J, Ducrocq R, Maier-Redelsperger M, Elion J, Labie D, Girot R.
    J Pediatr Hematol Oncol; 1997 Apr 02; 19(4):313-8. PubMed ID: 9256830
    [Abstract] [Full Text] [Related]

  • 18. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
    Wang WC, Wynn LW, Rogers ZR, Scott JP, Lane PA, Ware RE.
    J Pediatr; 2001 Dec 02; 139(6):790-6. PubMed ID: 11743503
    [Abstract] [Full Text] [Related]

  • 19. Effects of hydroxyurea on blood rheology in sickle cell anemia: A two-years follow-up study.
    Lemonne N, Möckesch B, Charlot K, Garnier Y, Waltz X, Lamarre Y, Antoine-Jonville S, Etienne-Julan M, Hardy-Dessources MD, Romana M, Connes P.
    Clin Hemorheol Microcirc; 2017 Dec 02; 67(2):141-148. PubMed ID: 28759962
    [Abstract] [Full Text] [Related]

  • 20. Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia.
    Opoka RO, Ndugwa CM, Latham TS, Lane A, Hume HA, Kasirye P, Hodges JS, Ware RE, John CC.
    Blood; 2017 Dec 14; 130(24):2585-2593. PubMed ID: 29051184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.